Avadel Pharmaceuticals To Join Russell 3000 Index, Effective At The Open Of Us Equity Markets On Monday, July 1, 2024
Portfolio Pulse from Benzinga Newsdesk
Avadel Pharmaceuticals (NASDAQ:AVDL) will join the Russell 3000 Index at the open of US equity markets on July 1, 2024, as part of the 2024 Russell US Indexes annual reconstitution.
June 27, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avadel Pharmaceuticals (NASDAQ:AVDL) will be added to the Russell 3000 Index on July 1, 2024. This inclusion is likely to increase the stock's visibility and attract more institutional investors.
Inclusion in the Russell 3000 Index typically leads to increased visibility and can attract more institutional investors, which may positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100